Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New antibiotic compounds discovered in soil
The new compounds, named malacidins, were found in soil samples collected from across America.

Malacidins found to eliminate MRSA in rats

Researchers in America have found a new family of antibiotics that can kill drug-resistant bacteria.

The antibiotics, called malacidins, have proven successful at killing several infections that are difficult to treat, including MRSA. Researchers say that discovery, published in Nature Microbiology brings fresh hope in the fight against antibiotic resistance.

In the study, researchers collected 1,800 soil samples from sites across America and used a gene sequencing technique to study them. When they found malacidins in many of the samples, they tested them on rats with induced MRSA and it completely eliminated the infection.

Speaking to BBC News, Dr Sean Brady from Rockefeller University said that his team are now working to improve the drug’s effectiveness so that it can be developed into a treatment for humans.

“It is impossible to say when, or even if, an early stage antibiotic discovery like the malacidins will proceed to the clinic,” he said. “It is a long, arduous road from the initial discovery of an antibiotic to a clinically used entity."

Antibiotic resistance is one of the biggest threats to global health, accelerated by the overuse of antibiotics as well as poor infection prevention and control.
According to the World Health Organisation, almost half a million people developed resistance to TB in 2016 and the issue is starting to complicate the fight against HIV and malaria.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'